about
Oxidized phospholipids as biomarkers of tissue and cell damage with a focus on cardiolipinAcid sphingomyelinase as target of Lycium Chinense: promising new action for cell healthThe role of oxidized phospholipids in atherosclerosis.Pathological aspects of lipid peroxidation.Oxygen toxicity and reactive oxygen species: the devil is in the details.The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine.Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer.Uptake and protein targeting of fluorescent oxidized phospholipids in cultured RAW 264.7 macrophages.Acid sphingomyelinase in macrophage biology.Short-term stimulation of calcium-permeable transient receptor potential canonical 5-containing channels by oxidized phospholipids.Editorial: Impact of Lipid Peroxidation on the Physiology and Pathophysiology of Cell Membranes.Implication of sphingomyelin/ceramide molar ratio on the biological activity of sphingomyelinase.Physical activity attenuates intermittent hypoxia-induced spatial learning deficits and oxidative stress.Stable and unstable lipid domains in ceramide-containing membranesApoptotic Bax at Oxidatively Stressed Mitochondrial Membranes: Lipid Dynamics and Permeabilization.Prevention of export of anoxia/reoxygenation injury from ischemic to nonischemic cardiomyocytes via inhibition of endocytosis.Regulation of lipid metabolism in breast cancer provides diagnostic and therapeutic opportunities
P2860
Q23909671-8993FF57-A08B-404D-8A9C-FEF543ACC733Q28821632-2C8460DC-ACB5-4E84-9250-4F76107B6191Q30436606-0A3E4EAD-E1B6-46D3-A2C3-881B55B0DBEAQ34137628-057D8DE8-F89D-46F3-9C6E-2A2C45A3BDB0Q34977549-505DE593-C40D-4C1D-AC5D-188D9C2B209BQ35021013-443DF6A2-E3EF-4DB3-871E-022F67BA43E2Q36249357-F0111B5C-2F39-44C8-8D1F-33C17692F01EQ37216241-A4045A26-3F11-4875-A4F6-4D7F8D6ED8DEQ37870853-CEE30C8A-2FD0-4C3F-9190-878C3C0C926EQ39716991-98A5A57C-4749-4629-9DA7-A061B1CCF29AQ42392514-3D2B44A2-3677-452E-886D-28C05FFE1A58Q42731878-C8946A87-BAAC-499F-85E5-DBBF6D401573Q42734293-2761A342-7AD0-4E91-BA5C-497B71C70608Q42853007-1F7C230F-D1B5-4388-816D-494A6D7AB373Q46361594-E261AC2E-ABF4-4494-9B8E-BF6270A55D72Q46900360-8B13811C-D436-4847-8695-F6A82EF82A9EQ57012149-B46083C6-A61F-43F5-BBE5-41570DF3384D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mediation of apoptosis by oxidized phospholipids.
@en
Mediation of apoptosis by oxidized phospholipids.
@nl
type
label
Mediation of apoptosis by oxidized phospholipids.
@en
Mediation of apoptosis by oxidized phospholipids.
@nl
prefLabel
Mediation of apoptosis by oxidized phospholipids.
@en
Mediation of apoptosis by oxidized phospholipids.
@nl
P1476
Mediation of apoptosis by oxidized phospholipids.
@en
P2093
Albin Hermetter
P304
P356
10.1007/978-1-4020-8831-5_13
P577
2008-01-01T00:00:00Z